Exhale

The official blog of the Lung Institute.

What are COPD Gold Guidelines?

24 Apr 2014
| Under COPD, Lung Disease | Posted by | 10 Comments
COPD guidelines

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease that can range from mild to severe. COPD is also an umbrella term and it includes emphysema and chronic bronchitis. The symptoms and prognosis depend upon the stage of the disease.

COPD GOLD Guidelines 

There are four stages categorized under the COPD GOLD Guidelines. These stages are part of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) system. The GOLD staging system of classification is the main system used by physicians to describe the severity of COPD.

Stages of COPD are determined through testing. The main test used to determine the stage of COPD is a pulmonary function test (PFT) or spirometry. It measures the amount of air a person can blow out, or exhale forcefully, in one second, called the forced expiratory volume (FEV1).

The GOLD staging system divides emphysema and COPD into four stages. The American Association for Respiratory Care also lists a Stage Zero on their chart (PDF), which means a person is at risk, though their only symptoms are chronic cough with mucus.

Stages of COPD

Stage I

Stage I is mild COPD. Patients in this stage have a chronic cough and mucus. But they may not even know they have COPD. They may make up the 12 million Americans with undiagnosed COPD.

Stage II

Stage II is moderate COPD. Patients may be experiencing more and more shortness of breath, even during everyday activities. This is usually the stage where patients see the physician to have their symptoms checked out.

Stage III

Stage III is severe COPD. Patients are having major difficulty with air flow, and their quality of life is compromised.

Stage IV

Stage IV is very severe COPD. Patients have severe airflow limitations, and their COPD exacerbations are dangerous. Quality of life usually goes down a lot.

Only a physician can accurately diagnose what stage of COPD you have, and help come up with a treatment plan. COPD is a progressive disease, but its symptoms can be treated and the progression can be slowed.


If you or a loved one has COPD or other lung disease and want to learn more about treatment options, contact us or call (800) 729-3065.

 

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.